Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Pending IPCI catalysts over next 6 months

-New CFO potentially announced
-PODRAS trials initiating
-Rexista CAT 3 HAP studies initiating
-Rexista/Purdue next litigation steps
-Potential partnership for Rexista version 1 with nPODDS(a potential Rexista partnership may also give partner the rights to Rexista version 2 with PODRAS...with PODRAS research totally funded by potential Rexista partner
-Regabatin partnership with lucrative up front payment...with Regabatin partner funding all forward research
-2 additional FocalinXR strengths still to be launched by PAR
-FDA approval of Pristiq(licensing agreement with Mallinckrodt secured already)
-FDA approval of Lamictal(licensing agreement with Mallinckrodt secured already)
-FDA approval of Protonix(licensing agreement still to be secured)
-FDA approval of Effexor(licensing agreement still to be secured)
-Next Glucophage and Keppra commercialization endeavors/potential partners announced